Global and United States Rhabdomyosarcoma Drug Market Research by Company, Type & Application 2013-2025

Publisher Name :
Date: 10-Jul-2018
No. of pages: 152

Summary

Market Segment as follows:

By Type

ARI-4175

Celyvir

Crizotinib

Enoblituzumab

AT-69

Axitinib

Others

By Application

Research Center

Hospital

Clinic

Others

By Company

Bellicum Pharmaceuticals Inc

Boehringer Ingelheim GmbH

Bristol-Myers Squibb Co

Celgene Corp

Eisai Co Ltd

Epizyme Inc

Exelixis Inc

Iproteos SL

Ipsen SA

MacroGenics Inc

NantKwest Inc

Novartis AG

Noxxon Pharma AG

Pfizer Inc

Taiho Pharmaceutical Co Ltd

Taiwan Liposome Company Ltd

Tarveda Therapeutics Inc

The main contents of the report including:

Section 1:

Product definition, type and application, global and United States market overview;

Section 2:

Global and United States Market competition by company;

Section 3:

Global and United States sales revenue, volume and price by type;

Section 4:

Global and United States sales revenue, volume and price by application;

Section 5:

United States export and import;

Section 6:

Company information, business overview, sales data and product specifications;

Section 7:

Industry chain and raw materials;

Section 8:

SWOT and Porter's Five Forces;

Section 9:

Conclusion.

Global and United States Rhabdomyosarcoma Drug Market Research by Company, Type & Application 2013-2025

Table of Contents
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 ARI-4175
1.1.2.2 Celyvir
1.1.2.3 Crizotinib
1.1.2.4 Enoblituzumab
1.1.2.5 AT-69
1.1.2.6 Axitinib
1.1.2.7 Others
1.1.3 Market by Application
1.1.3.1 Research Center
1.1.3.2 Hospital
1.1.3.3 Clinic
1.1.3.4 Others
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 Global and Regional Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 Global and Regional Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 Global and Regional Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 Regional Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 Bellicum Pharmaceuticals Inc
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Boehringer Ingelheim GmbH
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Bristol-Myers Squibb Co
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Celgene Corp
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Eisai Co Ltd
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Epizyme Inc
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Exelixis Inc
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Iproteos SL
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Ipsen SA
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 MacroGenics Inc
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 NantKwest Inc
6.12 Novartis AG
6.13 Noxxon Pharma AG
6.14 Pfizer Inc
6.15 Taiho Pharmaceutical Co Ltd
6.16 Taiwan Liposome Company Ltd
6.17 Tarveda Therapeutics Inc
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion

List of Tables

Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Bellicum Pharmaceuticals Inc
Table Sales Revenue, Volume, Price, Cost and Margin of Boehringer Ingelheim GmbH
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb Co
Table Sales Revenue, Volume, Price, Cost and Margin of Celgene Corp
Table Sales Revenue, Volume, Price, Cost and Margin of Eisai Co Ltd
Table Sales Revenue, Volume, Price, Cost and Margin of Epizyme Inc
Table Sales Revenue, Volume, Price, Cost and Margin of Exelixis Inc
Table Sales Revenue, Volume, Price, Cost and Margin of Iproteos SL
Table Sales Revenue, Volume, Price, Cost and Margin of Ipsen SA
Table Sales Revenue, Volume, Price, Cost and Margin of MacroGenics Inc
Table Sales Revenue, Volume, Price, Cost and Margin of NantKwest Inc
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis AG
Table Sales Revenue, Volume, Price, Cost and Margin of Noxxon Pharma AG
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer Inc
Table Sales Revenue, Volume, Price, Cost and Margin of Taiho Pharmaceutical Co Ltd
Table Sales Revenue, Volume, Price, Cost and Margin of Taiwan Liposome Company Ltd
Table Sales Revenue, Volume, Price, Cost and Margin of Tarveda Therapeutics Inc


List of Figures

Figure ARI-4175 Market Size and CAGR 2013-2017 (Million USD)
Figure ARI-4175 Market Size and CAGR 2013-2017 (Volume)
Figure ARI-4175 Market Forecast and CAGR 2018-2025 (Million USD)
Figure ARI-4175 Market Forecast and CAGR 2018-2025 (Volume)
Figure Celyvir Market Size and CAGR 2013-2017 (Million USD)
Figure Celyvir Market Size and CAGR 2013-2017 (Volume)
Figure Celyvir Market Forecast and CAGR 2018-2025 (Million USD)
Figure Celyvir Market Forecast and CAGR 2018-2025 (Volume)
Figure Crizotinib Market Size and CAGR 2013-2017 (Million USD)
Figure Crizotinib Market Size and CAGR 2013-2017 (Volume)
Figure Crizotinib Market Forecast and CAGR 2018-2025 (Million USD)
Figure Crizotinib Market Forecast and CAGR 2018-2025 (Volume)
Figure Enoblituzumab Market Size and CAGR 2013-2017 (Million USD)
Figure Enoblituzumab Market Size and CAGR 2013-2017 (Volume)
Figure Enoblituzumab Market Forecast and CAGR 2018-2025 (Million USD)
Figure Enoblituzumab Market Forecast and CAGR 2018-2025 (Volume)
Figure AT-69 Market Size and CAGR 2013-2017 (Million USD)
Figure AT-69 Market Size and CAGR 2013-2017 (Volume)
Figure AT-69 Market Forecast and CAGR 2018-2025 (Million USD)
Figure AT-69 Market Forecast and CAGR 2018-2025 (Volume)
Figure Axitinib Market Size and CAGR 2013-2017 (Million USD)
Figure Axitinib Market Size and CAGR 2013-2017 (Volume)
Figure Axitinib Market Forecast and CAGR 2018-2025 (Million USD)
Figure Axitinib Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Research Center Market Size and CAGR 2013-2017 (Million USD)
Figure Research Center Market Size and CAGR 2013-2017 (Volume)
Figure Research Center Market Forecast and CAGR 2018-2025 (Million USD)
Figure Research Center Market Forecast and CAGR 2018-2025 (Volume)
Figure Hospital Market Size and CAGR 2013-2017 (Million USD)
Figure Hospital Market Size and CAGR 2013-2017 (Volume)
Figure Hospital Market Forecast and CAGR 2018-2025 (Million USD)
Figure Hospital Market Forecast and CAGR 2018-2025 (Volume)
Figure Clinic Market Size and CAGR 2013-2017 (Million USD)
Figure Clinic Market Size and CAGR 2013-2017 (Volume)
Figure Clinic Market Forecast and CAGR 2018-2025 (Million USD)
Figure Clinic Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Rhabdomyosarcoma Drug Market Size and CAGR 2013-2017 (Million USD)
Figure Global Rhabdomyosarcoma Drug Market Size and CAGR 2013-2017 (Volume)
Figure Global Rhabdomyosarcoma Drug Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Rhabdomyosarcoma Drug Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Rhabdomyosarcoma Drug Market Size and CAGR 2013-2017 (Million USD)
Figure United States Rhabdomyosarcoma Drug Market Size and CAGR 2013-2017 (Volume)
Figure United States Rhabdomyosarcoma Drug Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Rhabdomyosarcoma Drug Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Rhabdomyosarcoma Drug SWOT List
Figure Life & Medical Porter's Five Forces
  • Global Erlotinib Hydrochloride Market Insights, Forecast to 2025
    Published: 14-Nov-2018        Price: US 4900 Onwards        Pages: 99
    This report presents the worldwide Erlotinib Hydrochloride market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. The Erlotinib Hydrochloride marke......
  • Global Oncology Drugs Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 3900 Onwards        Pages: 119
    This report studies the global market size of Oncology Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oncology Drugs in these regions. This research report categorizes the global Oncology Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportu......
  • Global Lenalidomide Market Insights, Forecast to 2025
    Published: 13-Nov-2018        Price: US 3900 Onwards        Pages: 111
    This report studies the global market size of Lenalidomide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Lenalidomide in these regions. This research report categorizes the global Lenalidomide market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities......
  • Global Cancer Targeted Therapy Market Size, Status and Forecast 2018-2025
    Published: 09-Nov-2018        Price: US 3900 Onwards        Pages: 111
    This report focuses on the global Cancer Targeted Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Targeted Therapy development in United States, Europe and China. In 2017, the global Cancer Targeted Therapy market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. The key players covered in this study - Advaxis ......
  • Global Neuroendocrine Carcinoma Drugs Market Research Report 2018
    Published: 09-Nov-2018        Price: US 2900 Onwards        Pages: 115
    This report studies the global Neuroendocrine Carcinoma Drugs market status and forecast, categorizes the global Neuroendocrine Carcinoma Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Xiaflex - Novartis AG - Roche - Molecular......
  • Global Carmustine Market Insights, Forecast to 2025
    Published: 08-Nov-2018        Price: US 3900 Onwards        Pages: 119
    This report studies the global market size of Carmustine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Carmustine in these regions. This research report categorizes the global Carmustine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenge......
  • Global Cancer Treatment Drugs Market Research Report 2018
    Published: 05-Nov-2018        Price: US 2900 Onwards        Pages: 126
    This report studies the global Cancer Treatment Drugs market status and forecast, categorizes the global Cancer Treatment Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Roche (Switzerland) - Novartis (Switzerland) - Celgene (U.S.)......
  • Global Cyclophosphamide Market Data Survey Report 2025
    Published: 05-Nov-2018        Price: US 1500 Onwards        Pages: 71
    Summary The global Cyclophosphamide market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Key manufacturers are included based on manufacturing sites, capacity an......
  • Global DNA Repair Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 05-Nov-2018        Price: US 3480 Onwards        Pages: 136
    DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body's innate DNA repair mechanism and aid in the treatme......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs